Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × tremelimumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 6 Liver Neoplasms 6 Small Cell Lung Carcinoma 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Cholangiocarcinoma 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Mesothelioma 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Neoadjuvant Therapy 5 Docetaxel 5 Radiation 4 Oxaliplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡